Drug May Help Prevent Resistance to Toxin-Based Leukemia Therapy

A new study has identified a possible strategy for improving the efficacy of a toxin-based cancer treatment, moxetumomab pasudotox, in some patients with acute lymphoblastic leukemia (ALL).

Cancer Currents: An NCI Cancer Research Blog